These data suggest that the strong phenotype in tumor cell migration observed in the in vitro brain slice cultures is not prominently manifested in vivo but only visible by reduced tumor volume during tumor progression and a trend in CD44-dependent reduction of tumor cell invasion upon CD44 deletion. This evidence concerns the gene CD44 and neoplasm.